Pediatric Endocrinologist; Professor
Dr. Cheril Clarson is a pediatric endocrinologist at the Children's Hospital (LHSC) whose research focuses on clinical trials in children and adolescents with both Type 1 and Type 2 diabetes, especially concerning the transition of diabetes care from adolescence to adulthood.
Dr. Clarson has experience in clinical trials using both medication and lifestyle intervention in obeseadolescents. She is a collaborator on TrialNet, an NIH-funded international network dedicated to the study, prevention, and early treatment of type 1 diabetes.
Dr. Cheril Clarson is a Paediatric Endocrinologist at the Children’s Hospital, London Health Sciences Centre, Professor in the Department of Paediatrics at the Schulich School of Medicine (Western University) and an Associate Scientist at the Lawson Health Research Institute. She trained in Paediatrics in both the UK and Canada.
Her current research focusses on clinical trials in type 1 diabetes. She is a member of the Juvenile Diabetes Research Foundation (JDRF) Canadian Clinical Trial Network Steering Committee. Dr. Clarson is Principal Investigator of a multicentre study of “Structured Transition on Diabetes Care in Adolescents with Type 1 Diabetes” (Transition Trial).
Dr. Cheril Clarson is a Paediatric Endocrinologist at the Children’s Hospital, London Health Sciences Centre, Professor in the Department of Paediatrics at the Schulich School of Medicine (Western University) and an Associate Scientist at the Lawson Health Research Institute. She trained in Pediatrics in both the UK and Canada and has been a member of the Department of Paediatrics in London, Ontario since 1985.
Research Interest Area: Diabetes
Research Overview: Pediatric diabetes; Type 1 diabetes prevention and preservation of beta cell function; Eating disorders; Transition to adult care; Pediatric obesity - lifestyle and medication interventions
Dr. Clarson is Section Head of Pediatric Endocrinology at the Children’s Hospital, London Health Sciences Centre, Associate Professor at the University of Western Ontario, and an Associate Scientist at the Lawson Health Research Institute.
Her research interests are in type 1 diabetes and obesity. She is a member of the JDRF Canadian Clinical Trial Network (CCTN) Steering Committee. Dr. Clarson is Principal Investigator on a multicentre study of Structured Transition on Diabetes Care in Adolescents with Type 1 Diabetes (Transition Trial). She is Principal Site Investigator for a JDRF Study on Continuous Glucose Monitoring (TIME Trial) and an International Cardio-Renal Intervention Trial (AdDit). Dr. Clarson is the Principal Site Investigator for the Trial to Reduce Insulin-dependent diabetes in the Genetically at Risk (TRIGR) and, for the Type 1 Diabetes Natural History Study and Pathways to Prevention (TrialNet). More recently, she has become Site Investigator for a North American study to reduce nocturnal hypoglycemia using algorithms and pump suspension called PSO4. She is also currently collaborating on an industry Phase III trial to evaluate the safety and efficacy of a long-acting insulin.
Aside from her research, Dr. Clarson participated in the 2003 Clinical Practice Guidelines Committee and the Network of Ontario Pediatric Diabetes program. Between 2006 and 2010 she served as a Councillor, Clinical & Scientific Section, Executive Committee, Canadian Diabetes Association and as a member of the Canadian Diabetes Association National Advocacy Council.
Dr. Clarson was also president of the Canadian Pediatric Endocrine Group (CPEG) from 2007 to 2009 and chaired the Organizing and Scientific Committee for the 2007 Scientific Meeting held in London, Ontario.
×
About Cheril Clarson
Dr. Cheril Clarson is a pediatric endocrinologist at the Children's Hospital (LHSC) whose research focuses on clinical trials in children and adolescents with both Type 1 and Type 2 diabetes, especially concerning the transition of diabetes care from adolescence to adulthood.
Dr. Clarson has experience in clinical trials using both medication and lifestyle intervention in obeseadolescents. She is a collaborator on TrialNet, an NIH-funded international network dedicated to the study, prevention, and early treatment of type 1 diabetes.
Dr. Cheril Clarson is a Paediatric Endocrinologist at the Children’s Hospital, London Health Sciences Centre, Professor in the Department of Paediatrics at the Schulich School of Medicine (Western University) and an Associate Scientist at the Lawson Health Research Institute. She trained in Paediatrics in both the UK and Canada.
Her current research focusses on clinical trials in type 1 diabetes. She is a member of the Juvenile Diabetes Research Foundation (JDRF) Canadian Clinical Trial Network Steering Committee. Dr. Clarson is Principal Investigator of a multicentre study of “Structured Transition on Diabetes Care in Adolescents with Type 1 Diabetes” (Transition Trial).
Dr. Cheril Clarson is a Paediatric Endocrinologist at the Children’s Hospital, London Health Sciences Centre, Professor in the Department of Paediatrics at the Schulich School of Medicine (Western University) and an Associate Scientist at the Lawson Health Research Institute. She trained in Pediatrics in both the UK and Canada and has been a member of the Department of Paediatrics in London, Ontario since 1985.
Research Interest Area: Diabetes
Research Overview: Pediatric diabetes; Type 1 diabetes prevention and preservation of beta cell function; Eating disorders; Transition to adult care; Pediatric obesity - lifestyle and medication interventions
Dr. Clarson is Section Head of Pediatric Endocrinology at the Children’s Hospital, London Health Sciences Centre, Associate Professor at the University of Western Ontario, and an Associate Scientist at the Lawson Health Research Institute.
Her research interests are in type 1 diabetes and obesity. She is a member of the JDRF Canadian Clinical Trial Network (CCTN) Steering Committee. Dr. Clarson is Principal Investigator on a multicentre study of Structured Transition on Diabetes Care in Adolescents with Type 1 Diabetes (Transition Trial). She is Principal Site Investigator for a JDRF Study on Continuous Glucose Monitoring (TIME Trial) and an International Cardio-Renal Intervention Trial (AdDit). Dr. Clarson is the Principal Site Investigator for the Trial to Reduce Insulin-dependent diabetes in the Genetically at Risk (TRIGR) and, for the Type 1 Diabetes Natural History Study and Pathways to Prevention (TrialNet). More recently, she has become Site Investigator for a North American study to reduce nocturnal hypoglycemia using algorithms and pump suspension called PSO4. She is also currently collaborating on an industry Phase III trial to evaluate the safety and efficacy of a long-acting insulin.
Aside from her research, Dr. Clarson participated in the 2003 Clinical Practice Guidelines Committee and the Network of Ontario Pediatric Diabetes program. Between 2006 and 2010 she served as a Councillor, Clinical & Scientific Section, Executive Committee, Canadian Diabetes Association and as a member of the Canadian Diabetes Association National Advocacy Council.
Dr. Clarson was also president of the Canadian Pediatric Endocrine Group (CPEG) from 2007 to 2009 and chaired the Organizing and Scientific Committee for the 2007 Scientific Meeting held in London, Ontario.
| Present | Associate Scientist, Lawson Health Research Institute ‐ Children's Health Research Institute (CHRI) | |
|
|
||
| Present | Pediatric Endocrinologist, London Health Sciences Centre ‐ Children's Hospital | |
|
|
||
| Present | Professor, Western University ‐ Department of Paediatrics | |
|
|
||